Portfolio News

Announcing our latest investment led by Spectrum Equity and McKesson Ventures

RxVantage recently shared news of its latest investment directed by McKesson Ventures and Spectrum Equity. These two investors will be joining RxVantage’s existing investors, which include Merck Global Health Innovation Fund, Slater Technology Fund, Javelin Venture Partners, and dRx Capital. RxVantage’s goal is to promote technology that allows professionals in healthcare and life science to collaborate seamlessly, safely, and effectively. Its technology allows medical practices to get important resources, wherever and whenever they are needed. The new investment is following a time of notable growth for...

MM+M Podcast 1.18.22: Digital health’s funding frenzy (and what it means)

Rock Health Head of Consulting Sari Kaganoff appeared on the MM+M (Medical, Marketing + Media) podcast to unpack the numbers and interpret the directional signs behind last year’s frenzied funding environment for digital health. She said 2021 was a big year for digital health, noting that $29.1 billion was raised by venture-backed startups, according to Rock Health data. This is almost twice the prior year and much higher than years before that. The average deal size increased very notably for series D and above, Kaganoff said....

First Venture Fund for Black-Owned Health Startups Launches with $55 Million

Health-tech startups have experienced immense success over the past two years. The need for remote care skyrocketed, and many digital health services found themselves outpacing initial growth projections as $29.1 billion was funneled into U.S. digital health startups in 2021 alone, according to Rock Health data. The surge in funding wasn’t felt by everyone, though. According to a 2020 Rock Health survey of nearly 700 health startup leaders, support for Black founders was inadequate. This inequity resulted in Black founders being more likely to bootstrap their...

Drugs by Drone: Good Idea?

With positive results from early tests, the drone industry is hopeful that lawmakers will increase their leniency in regulating drones. With this hope come questions about what should be considered a drone-deliverable item, specifically when it comes to controlled substances like pharmaceuticals. There are many angles to this discussion, though Amazon and CVS have already teased medication delivery by drone. Some hurdles still stand in the way of drones delivering medication: Certain populations will be excluded from service because of drone regulations, drones can be shot...

AllStripes: How this HealthTech Company Leverages Science to Advance Rare Disease Research (Pt. 1 & Pt. 2)

A two-part interview with AllStripes co-founder Nancy Yu on PatientWorthy went in depth about Yu’s background, why she started the company, and plans for the future. It begins by highlighting her interest in how science and technology interact with one another. Yu explained how growing up near the technology industry in the Bay Area had an impact on her career path. “I was at an intersection between doing science and research in the lab and trying to figure out how to get that technology into the...